Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Simeng Zhu
Institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center
Observed institutions:
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
The Ohio State University Wexner Medical Center
ORCID:
0000-0003-0850-6690
Observed ORCID:
0000-0003-0850-6690
OpenAlex ID:
A5127961078
Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review
2026
·
Tugce Kutuk
, Ece Atak
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
Association of Systemic Inflammation Response Index With Long-Term Outcomes in Patients With Head and Neck Cancer Receiving Definitive Chemoradiation
2026
·
Sung Jun Ma
, Andrew Koempel
, et al.
·
JCO oncology advances.
·
2
Early Integrated Neuropsychological Care for Patients With Brain Metastases: A Randomized Controlled Trial (ATHENA Trial)
2026
·
Haley K. Perlow
, Erica L. Dawson
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Improved Progression-Free Survival Following Dose-Escalated Versus Standard-Dose Postoperative Radiation Therapy for High-Risk Meningiomas: An International Multicenter Individual Patient–Level Meta-Analysis (FIRESTORM)
2026
·
Raj Singh
, Andrew Koempel
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Nodular Meningeal Recurrence After Laser Interstitial Thermal Therapy for Brain Metastasis: Diagnostic Challenges and Role of Reirradiation With Preoperative Fractionated Stereotactic Radiation Therapy
2026
·
Marshall Harrell
, Tugce Kutuk
, et al.
·
Advances in Radiation Oncology
·
1
PDF
Association of pre-treatment hemoglobin level as a prognostic factor for survival outcomes in head and neck cancer patients treated with definitive radiation.
2026
·
Nandini Bangalore
, Maximos McCune
, et al.
·
Journal of Clinical Oncology
Second-line cetuximab plus immune checkpoint inhibitor (ICI) versus cetuximab plus carboplatin and paclitaxel following ICI-containing regimen in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
2026
·
Jennifer Dorcas Hwang
, Mateus Trinconi Cunha
, et al.
·
Journal of Clinical Oncology
Cytokine dynamics in a phase II trial of metronomic carboplatin/paclitaxel combined with cemiplimab in recurrent/metastatic head and neck squamous cell carcinoma.
2026
·
Marcelo Raul Bonomi
, Jungmin Shin
, et al.
·
Journal of Clinical Oncology
Abstract 3871: Molecular correlates of response and survival in a phase II trial of weekly carboplatin/paclitaxel plus cemiplimab (wCP+C) in advanced/metastatic mucosal head and neck squamous cell carcinoma (a/mHNSCC).
2026
·
Mateus Trinconi Cunha
, Fahad Rind
, et al.
·
Cancer Research
Impact of Treatment Package Time on Survival in Patients with Head and Neck Adenoid Cystic Carcinoma
2026
·
Emile Gogineni
, Ela Kini
, et al.
·
Cancers
PDF
Long-Term Outcomes of Weekly Cisplatin Versus Carboplatin and Paclitaxel for Head and Neck Cancer
2026
·
Sung Jun Ma
, Kevin E. Agner
, et al.
·
JCO oncology advances.
PDF
Show more works
View as search
Works count:
11
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type